MedPath

RABEPRAZOLE EC

RABEPRAZOLE EC

Approved
DIN Number

02356538

Drug Class

Human

Market Date

Nov 23, 2010

Company
HC

sanis health inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02356538
AIG Number0143681002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A02BC04 RABEPRAZOLE
Product Specifications
Dosage FormTablet (Enteric-Coated)
Route of AdministrationOral
AHFS Classification56:28.36
Health Canada Classification

ACTIVE INGREDIENTS (1)

RABEPRAZOLE SODIUMActive
Strength: 20 MG
Monograph: RABEPRAZOLE SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.